Exponential Biotherapies
The Hague
About Exponential Biotherapies
Exponential Biotherapies operates as a drug discovery and development company. It provides small molecule drugs to treat a range of severe inflammatory disorders, such as acute kidney injury, septic shock, radiation sickness, and avian influenza infections.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $10.5M
- Last round: Series Unknown (Jan 2007)
- Website: expobio.com
- Phone: (703) 883-3701
Industries & Categories
Alternative Medicine, Biotechnology, Medical, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/exponential-biotherapies-3387897 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.